Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder

Table 4

QLQ-BLM30

QLQ-BLM30	Ileal conduit; Mean ± standard dev.; Median (interquartile range); 𝑛=number of cases	Ileal neobladder; Mean ± standard dev.; Median (interquartile range); 𝑛=number of cases
Urinary symptom		33.6±26.3
		33.3 (9.5–52.4)
		𝑛=33
Urostomy problem	25.6±22.0
	19.4 (6.9–43.8)
	𝑛=24
Single catheter use problem	0±0	6.7±14.9
	0 (0-0)	0 (0–16.7)
	𝑛=1	𝑛=5
Future perspective	39.1±33.8	24.3±27.9
	33.3 (11.1–66.7)	11.1 (0–44.4)
	𝑛=23	𝑛=32
Abdominal bloating and flatulence	28.3±25.8	29.7±31.0
	33.3 (0–50.0)	16.7 (0–50)
	𝑛=23	𝑛=32
Body image	34.1±32.3	33.5±28.2
	22.2 (11.1–55.6)	33.3 (11.1–55.6)
	𝑛=23	𝑛=32
Sexual functioning	no available data	no available data

EORTC QLQ-BLM30 results of this study. The questionnaire is a phase-3 module that specifically evaluates the impact of radical cystectomy and reconstructive surgery in terms of health-related quality of life. For all the questions, a scale from 1 to 4 was used (1: not at all, 2: a little, 3: quite a bit, 4: very much). All scores were linearly transformed such that all scales range from 0 to 100. For the symptoms/single items, a higher score means a higher level of symptomatology/problems.